D'AMICO, MASSIMO
D'AMICO, MASSIMO
Medicina Sperimentale e Clinica
A metal-supported biomimetic micromembrane allowing the recording of single channel activity and of impedance spectra of membrane proteins.
2010 L. Becucci; M. D'Amico; S. Daniele; M. Olivotto; A. Pozzi; R. Guidelli
Acycloguanosyl 5'-thymidyltriphosphate, a Thymidine Analogue Prodrug Activated by Telomerase, Reduces Pancreatic Tumor Growth in Mice.
2011 S.Polvani; M.Calamante; V.Foresta; E.Ceni; A.Mordini; A.Quattrone; M.D'Amico; C.Luchinat; I.Bertini; A.Galli
Breast cancer resistance protein (BCRP) expression and activity in mitochondria of different multiple drug-resistant (MDR) cancer cell lines
2009 Mazzanti, R; Solazzo, M; Fantappie, O; D'Amico, M; Sassoli, C; Tani, A; Cipriani, G; Bogani, C; Pestrin, M; Formigli, L
Cell imaging and manipulation by nonlinear optical microscopy
2006 L. Sacconi; I. M. Tolic-Nørrelykke; M. D'Amico; F. Vanzi; M. Olivotto; R. Antolini; F.S. Pavone
Cell renewing in neuroblastoma: electrophysiological and immunocytochemical characterization of stem cells and derivatives.
2006 BIAGIOTTI T.; D'AMICO M.; MARZI I.; DI GENNARO P.; A. ARCANGELI; WANKE E.; OLIVOTTO M.
Circulating Endothelial Progenitor Cells in Type 1 Diabetic Patients: Relation with Patients' Age and Disease Duration.
2017 Arcangeli A, Lastraioli E, Piccini B, D'Amico M, Lenzi L, Pillozzi S, Calabrese M, Toni S, Arcangeli A
COUP-TFII in pancreatic adenocarcinoma: Clinical implication for patient survival and tumor progression.
2013 S. Polvani;M. Tarocchi;S. Tempesti;T. Mello;E. Ceni;F. Buccoliero;M. D'Amico;V. Boddi;M. Farsi;S. Nesi;G. Nesi;S. Milani;A. Galli
HDAC-inhibitor (S)-8 disrupts HDAC6-PP1 complex prompting A375 melanoma cell growth arrest and apoptosis.
2014 Balliu, Manjola; Guandalini, Luca; Romanelli, Maria Novella; D'Amico, Massimo; Paoletti, Francesco
hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma
2015 Lastraioli, E; Perrone, G.; Sette, A.; Fiore, A.; Crociani, O.; Manoli, S.; D'Amico, M.; Masselli, M.; Iorio, J.; Callea, M.; Borzomati, D.; Nappo, G.; Bartolozzi, F.; Santini, D.; Bencini, L.; Farsi, M.; Boni, L.; Di Costanzo, F.; Schwab, A.; Onetti Muda, A.; Coppola, R.; Arcangeli, A.
hERG1 channels modulate integrin signaling to trigger angiogenesis and tumor progression in colorectal cancer
2013 O Crociani; F Zanieri; S Pillozzi; E Lastraioli; M Stefanini; A Fiore; A Fortunato; M D'Amico; M Masselli; E De Lorenzo; L Gasparoli; M Chiu; O Bussolati; A Becchetti; A Arcangeli
hERG1 Channels Regulate VEGF-A Secretion in Human Gastric Cancer: Clinicopathological Correlations and Therapeutical Implications
2014 Crociani O; Lastraioli E; Boni L; Pillozzi S; Romoli MR; D'Amico M; Stefanini M; Crescioli S; Taddei A; Bencini L; Bernini M; Farsi M; Beghelli S; Scarpa A; Messerini L; Tomezzoli A; Vindigni C; Morgagni P; Saragoni L; Giommoni E; Gasperoni S; Di Costanzo F; Roviello F; De Manzoni G; Bechi P; Arcangeli A.
Hypoxia-resistant profile implies vulnerability of cancer stem cells to physiological agents, which suggests new therapeutic targets.
2014 Cipolleschi MG; Marzi I; Santini R; Fredducci D; Vinci MC; D'Amico M; Rovida E; Stivarou T; Torre E; Dello Sbarba P; Stecca B; Olivotto M.
Identification of Non-Cardiotoxic hERG1 Blockers to Overcome Chemoresistance in Acute Lymphoblastic Leukemias
2012 Marika Masselli; Serena Pillozzi; Massimo D'Amico
Incorporation of the HERG potassium channel in a mercury supported lipid bilayer.
2008 L. BECUCCI; M. CARBONE; T. BIAGIOTTI; M. D'AMICO; M. OLIVOTTO; R. GUIDELLI
Long-term modulation of HERG channel gating in hypoxia
2001 FONTANA L.; D'AMICO M.; CROCIANI O.; BIAGIOTTI T.; SOLAZZO M.; ROSATI B.; ARCANGELI A.; WANKE E.; M. OLIVOTTO
Macrolide antibiotics exert antileukemic effects by modulating the autophagic flux through inhibition of hERG1 potassium channels
2016 Pillozzi, S.; Masselli, M.; Gasparoli, L.; D'Amico, M.; Polletta, L.; Veltroni, M.; Favre, C.; Basso, G.; Becchetti, A.; Arcangeli, A.
Mitochondrial expression and functional activity of Breast Cancer Resistance Protein in different multiple drug-resistant cell lines
2009 M. Solazzo; O. FANTAPPIE'; M. D'Amico; C. Sassoli; A. Tani; G. Cipriani; C. Bogani; L. Formigli; R. Mazzanti
NAMI-A is highly cytotoxic toward leukaemia cell lines: evidence of inhibition of KCa 3.1 channels
2014 S Pillozzi; L Gasparoli; M Stefanini; M Ristori; M D'Amico; E Alessio; F Scaletti; A Becchetti; A Arcangeli; L Messori
New concepts about fibroblasts trophic function
2013 Alice Santi; Anna Caselli; Francesco Ranaldi; Paolo Paoli; Massimo D'Amico; Stefano Stinziani; Paolo Cirri
Potassium channels: novel emerging biomarkers and targets for therapy in cancer.
2013 D'Amico M;Gasparoli L;Arcangeli A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A metal-supported biomimetic micromembrane allowing the recording of single channel activity and of impedance spectra of membrane proteins. | 2010 | L. Becucci; M. D'Amico; S. Daniele; M. Olivotto; A. Pozzi; R. Guidelli | |
| Acycloguanosyl 5'-thymidyltriphosphate, a Thymidine Analogue Prodrug Activated by Telomerase, Reduces Pancreatic Tumor Growth in Mice. | 2011 | S.Polvani; M.Calamante; V.Foresta; E.Ceni; A.Mordini; A.Quattrone; M.D'Amico; C.Luchinat; I.Bertini; A.Galli | |
| Breast cancer resistance protein (BCRP) expression and activity in mitochondria of different multiple drug-resistant (MDR) cancer cell lines | 2009 | Mazzanti, R; Solazzo, M; Fantappie, O; D'Amico, M; Sassoli, C; Tani, A; Cipriani, G; Bogani, C; Pestrin, M; Formigli, L | |
| Cell imaging and manipulation by nonlinear optical microscopy | 2006 | L. Sacconi; I. M. Tolic-Nørrelykke; M. D'Amico; F. Vanzi; M. Olivotto; R. Antolini; F.S. Pavone | |
| Cell renewing in neuroblastoma: electrophysiological and immunocytochemical characterization of stem cells and derivatives. | 2006 | BIAGIOTTI T.; D'AMICO M.; MARZI I.; DI GENNARO P.; A. ARCANGELI; WANKE E.; OLIVOTTO M. | |
| Circulating Endothelial Progenitor Cells in Type 1 Diabetic Patients: Relation with Patients' Age and Disease Duration. | 2017 | Arcangeli A, Lastraioli E, Piccini B, D'Amico M, Lenzi L, Pillozzi S, Calabrese M, Toni S, Arcangeli A | |
| COUP-TFII in pancreatic adenocarcinoma: Clinical implication for patient survival and tumor progression. | 2013 | S. Polvani;M. Tarocchi;S. Tempesti;T. Mello;E. Ceni;F. Buccoliero;M. D'Amico;V. Boddi;M. Farsi;S. Nesi;G. Nesi;S. Milani;A. Galli | |
| HDAC-inhibitor (S)-8 disrupts HDAC6-PP1 complex prompting A375 melanoma cell growth arrest and apoptosis. | 2014 | Balliu, Manjola; Guandalini, Luca; Romanelli, Maria Novella; D'Amico, Massimo; Paoletti, Francesco | |
| hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma | 2015 | Lastraioli, E; Perrone, G.; Sette, A.; Fiore, A.; Crociani, O.; Manoli, S.; D'Amico, M.; Masselli, M.; Iorio, J.; Callea, M.; Borzomati, D.; Nappo, G.; Bartolozzi, F.; Santini, D.; Bencini, L.; Farsi, M.; Boni, L.; Di Costanzo, F.; Schwab, A.; Onetti Muda, A.; Coppola, R.; Arcangeli, A. | |
| hERG1 channels modulate integrin signaling to trigger angiogenesis and tumor progression in colorectal cancer | 2013 | O Crociani; F Zanieri; S Pillozzi; E Lastraioli; M Stefanini; A Fiore; A Fortunato; M D'Amico; M Masselli; E De Lorenzo; L Gasparoli; M Chiu; O Bussolati; A Becchetti; A Arcangeli | |
| hERG1 Channels Regulate VEGF-A Secretion in Human Gastric Cancer: Clinicopathological Correlations and Therapeutical Implications | 2014 | Crociani O; Lastraioli E; Boni L; Pillozzi S; Romoli MR; D'Amico M; Stefanini M; Crescioli S; Taddei A; Bencini L; Bernini M; Farsi M; Beghelli S; Scarpa A; Messerini L; Tomezzoli A; Vindigni C; Morgagni P; Saragoni L; Giommoni E; Gasperoni S; Di Costanzo F; Roviello F; De Manzoni G; Bechi P; Arcangeli A. | |
| Hypoxia-resistant profile implies vulnerability of cancer stem cells to physiological agents, which suggests new therapeutic targets. | 2014 | Cipolleschi MG; Marzi I; Santini R; Fredducci D; Vinci MC; D'Amico M; Rovida E; Stivarou T; Torre E; Dello Sbarba P; Stecca B; Olivotto M. | |
| Identification of Non-Cardiotoxic hERG1 Blockers to Overcome Chemoresistance in Acute Lymphoblastic Leukemias | 2012 | Marika Masselli; Serena Pillozzi; Massimo D'Amico | |
| Incorporation of the HERG potassium channel in a mercury supported lipid bilayer. | 2008 | L. BECUCCI; M. CARBONE; T. BIAGIOTTI; M. D'AMICO; M. OLIVOTTO; R. GUIDELLI | |
| Long-term modulation of HERG channel gating in hypoxia | 2001 | FONTANA L.; D'AMICO M.; CROCIANI O.; BIAGIOTTI T.; SOLAZZO M.; ROSATI B.; ARCANGELI A.; WANKE E.; M. OLIVOTTO | |
| Macrolide antibiotics exert antileukemic effects by modulating the autophagic flux through inhibition of hERG1 potassium channels | 2016 | Pillozzi, S.; Masselli, M.; Gasparoli, L.; D'Amico, M.; Polletta, L.; Veltroni, M.; Favre, C.; Basso, G.; Becchetti, A.; Arcangeli, A. | |
| Mitochondrial expression and functional activity of Breast Cancer Resistance Protein in different multiple drug-resistant cell lines | 2009 | M. Solazzo; O. FANTAPPIE'; M. D'Amico; C. Sassoli; A. Tani; G. Cipriani; C. Bogani; L. Formigli; R. Mazzanti | |
| NAMI-A is highly cytotoxic toward leukaemia cell lines: evidence of inhibition of KCa 3.1 channels | 2014 | S Pillozzi; L Gasparoli; M Stefanini; M Ristori; M D'Amico; E Alessio; F Scaletti; A Becchetti; A Arcangeli; L Messori | |
| New concepts about fibroblasts trophic function | 2013 | Alice Santi; Anna Caselli; Francesco Ranaldi; Paolo Paoli; Massimo D'Amico; Stefano Stinziani; Paolo Cirri | |
| Potassium channels: novel emerging biomarkers and targets for therapy in cancer. | 2013 | D'Amico M;Gasparoli L;Arcangeli A |